MyPrurigoTeam

Both Dupixent (dupilumab) and Nemluvio (nemolizumab) are FDA-approved biologic injections for prurigo nodularis in adults, but they work in different ways and have different dosing schedules.

Here's a quick comparison:

Dupixent
- Targets IL-4 receptors to reduce inflammation
- Given as an injection every other week (after Show Full Answer

Both Dupixent (dupilumab) and Nemluvio (nemolizumab) are FDA-approved biologic injections for prurigo nodularis in adults, but they work in different ways and have different dosing schedules.

Here's a quick comparison:

Dupixent
- Targets IL-4 receptors to reduce inflammation
- Given as an injection every other week (after a larger starting dose)
- Common side effects: nasal/throat inflammation, eye inflammation, herpes infections, dizziness, muscle pain, diarrhea

Nemluvio
- Targets IL-31, a protein that triggers itch and inflammation
- Given as an injection every four weeks
- Comes as a prefilled dual-chamber pen (needs to be mixed before use)
- Dose depends on body weight
- Common side effects: headache, skin irritation/eczema

Both carry a rare risk of serious allergic reactions. The best choice between the two really depends on your specific symptoms, medical history, and what your dermatologist recommends. It's worth having that conversation with them to figure out which option suits you best.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

90% Have Less Itch After 2 Years on Nemolizumab, Study Finds

Treatments

Dupixent

Nemluvio